Do measures to control MRSA work?

September 02, 2004

Proof that MRSA control policies in hospitals work is poor, show researchers in this week's BMJ.

But they stress that, although better studies are urgently needed, isolation measures should continue until further research establishes otherwise.

The level of hospital acquired MRSA continues to rise globally. National guidelines in many countries recommend patient isolation to control its spread, but the effectiveness of these measures has never been tested scientifically.

The team analysed 46 studies on MRSA isolation policies published between 1966 and 2000. No conclusions could be drawn in a third of studies, while major weaknesses in others means that plausible alternative explanations for reducing MRSA cannot be excluded, say the authors.

Six studies provided stronger evidence. Four showed that concerted efforts including isolation measures can substantially reduce the spread of MRSA, even when endemic. Yet, in two others, isolation wards failed to prevent endemic MRSA. "These studies indicate a need to investigate precisely how such isolation measures should be used," they add.

Despite all the limitations of existing studies, a lack of evidence of an effect should not be mistaken for evidence of lack of effect, say the authors. "Having considered the evidence, we believe isolation measures recommended in national guidelines should continue until further research establishes otherwise."

"We do need better studies, but we must have faith in the strength of common sense and practical experience when it comes to evaluating infection control measures," adds Dr Andreas Voss, an expert from The Netherlands, where MRSA levels are low.

The fact that The Netherlands and Scandinavia are still able to control MRSA by employing the most intensive "search and destroy" measures should not be ignored. The argument that efforts to control MRSA are insufficient and costly could not be further from the truth, he concludes.
-end-


BMJ

Related MRSA Articles from Brightsurf:

Widely available antibiotics could be used in the treatment of 'superbug' MRSA
Some MRSA infections could be tackled using widely-available antibiotics, suggests new research from an international collaboration led by scientists at the University of Cambridge and the Wellcome Sanger Institute.

Computer model shows how to better control MRSA outbreaks
A research team led by scientists at the Columbia University Mailman School of Public Health report on a new method to help health officials control outbreaks of methicillin-resistant Staphylococcus aureus, or MRSA, a life-threatening antibiotic-resistant infection often seen in hospitals.

Using MRSA's strength against it
MRSA evolved to become a deadly killer because it's wily and resilient.

Livestock-associated MRSAfound among MRSA from humans
The survey results show more frequent detections and geographical dispersion of LA-MRSA in humans in the EU/EEA since 2007, and highlight the public health and veterinary importance of LA-MRSA as a 'One Health' issue.

Fighting MRSA with new membrane-busting compounds
Public health officials are increasingly concerned over methicillin-resistant Staphylococcus aureus (MRSA).

Know thy enemy: Kill MRSA with tailored chemistry
UConn medicinal chemists have developed experimental antibiotics that kill MRSA, a common and often deadly bacteria that causes skin, lung, and heart infections.

MRSA uses decoys to evade a last-resort antibiotic
The superbug MRSA uses decoys to evade a last-resort antibiotic, reveals new research.

Scientists find a salty way to kill MRSA
Scientists have discovered a new way to attack Staphylococcus aureus bacteria.

Experimental antibiotic treats deadly MRSA infection
A new experimental antibiotic developed by a team of scientists at Rutgers University successfully treats the deadly MRSA infection and restores the efficacy of a commonly prescribed antibiotic that has become ineffective against MRSA.

OU team develops new antibiotic to fight MRSA
A University of Oklahoma team of chemists has developed a new antibiotic formulation to fight the sometimes deadly staph infection caused by methicillin-resistant S. aureus or MRSA and other antibiotic-resistant infectious bacteria.

Read More: MRSA News and MRSA Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.